Multiple sclerosis: major histocompatibility complexity and antigen presentation
Posted Mon, 01/04/2010 - 07:24
Publication Type:
Journal ArticleSource:
Genome Med, Volume 1, Number 11, p.105-105 (2009)URL:
http://www.hubmed.org/display.cgi?uids=19895714Abstract:
ABSTRACT: Multiple sclerosis (MS), like many putative autoimmune diseases, has been known to be associated with the human leukocyte antigen (HLA) class II region for more than 3 decades. However, exactly how HLA class II alleles increase the risk of MS is not yet conclusively known. Recent work in large human cohorts has highlighted the fact that nearly all common HLA-DRB1 allelotypes are either positively or negatively associated with the disease, detracting from allele-specific antigen presentation as the sole mechanism of MHC associated disease susceptibility. Here, we put into context recent data on the HLA class II region in MS, including allelic heterogeneity, gene-environment interactions and epigenetics. It is clear that a complete understanding of the epistatic interactions and epigenetic features of this region will be crucial to comprehending disease pathogenesis.Other stories you might want to see…
- A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01
- Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex
- Regulation of major histocompatibility complex class II gene expression, genetic variation and disease
- Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls
- Multiple Sclerosis Scotland: MS Gene Expression is Regulated By ...












